Literature DB >> 12235284

Domains of type 1 protein phosphatase inhibitor-2 required for nuclear and cytoplasmic localization in response to cell-cell contact.

Craig Leach1, Masumi Eto, David L Brautigan.   

Abstract

Inhibitor-2 of type 1 protein phosphatase is a phosphoprotein conserved among all eukaryotes, and it appears in both the nucleus and cytoplasm of tissue culture cells. We discovered that endogenous inhibitor-2 is concentrated in the nucleus of cells cultured at low density, whereas cells growing at high density excluded inhibitor-2 from the nucleus. There was rapid redistribution of inhibitor-2 when cells were replated at low or high density. Localization of myc-tagged forms of inhibitor-2 showed that residues 119-197 were required for nuclear accumulation in low-density cells and residues 78-119 were required for cytoplasmic localization in high-density cells. Fusion of inhibitor-2 residues 78-119 to green fluorescent protein was sufficient to produce cytoplasmic retention. Inhibitor-2 fused to triple tandem green fluorescent protein (100 kDa) was imported into the nucleus of low-density cells but was not excluded from the nucleus when cells reached high density, implying that inhibitor-2 was actively imported into the nucleus but exited by passive diffusion instead of active export. We conclude that inhibitor-2 contains two separate domains that control its localization in the nucleus or cytoplasm. This change in inhibitor-2 localization may direct inhibitor-2 to different forms of protein phosphatase 1 or change the localization of protein phosphatase, as part of the cellular response to cell-cell contacts at high density.

Mesh:

Substances:

Year:  2002        PMID: 12235284     DOI: 10.1242/jcs.00052

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  4 in total

1.  Macromolecular crowding effect is critical for maintaining SIRT1's nuclear localization in cancer cells.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Cycle       Date:  2016-07-27       Impact factor: 4.534

2.  Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells.

Authors:  Masumi Eto; Jason A Kirkbride; Rishika Chugh; Nana Kofi Karikari; Jee In Kim
Journal:  Biochem Biophys Res Commun       Date:  2013-03-26       Impact factor: 3.575

3.  Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy.

Authors:  Aline Fréville; Katia Cailliau-Maggio; Christine Pierrot; Géraldine Tellier; Hadidjatou Kalamou; Sophia Lafitte; Alain Martoriati; Raymond J Pierce; Jean-François Bodart; Jamal Khalife
Journal:  BMC Biol       Date:  2013-07-09       Impact factor: 7.431

4.  The expression and localization of a novel protein phosphatase inhibitor 2810408A11Rik in mouse testis and sperm.

Authors:  Ye Bi; Mingxi Liu; Wenjiao Tu; Yibo Wu; Xuejiang Guo; Zuomin Zhou; Jiahao Sha
Journal:  J Biomed Res       Date:  2012-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.